|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Tyco International Ltd. TYC, a diversified manfacturer with substantial medical product lines. |
|---|---|
| Transferring Party | Floreane Medical Implants SA (France), a manufacturer of Sofradim surgical mesh implants to provide tissue reinforcement for procedures such as hernia repair, pelvic floor reconstruction, incontinence, urinary, adhesion prevention and obesity surgery. |
| Sector | Medical Devices |
| Date | September 21, 2005 |
| Analysis Expands Tyco's surgical product portfolio, with a complementary range of products, and allows Tyco to capitalize on its global sales force and infrastructure. Deal value of $145 million for 41% of the shares and a 55% voting interest. Floreane's sales in 2004 were $31 million. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |